Finance

Beta
Ask
Lists
BLRX:NASDAQ
BioLine RX Ltd - ADR
3,37 US$
-0,88%
(-0,030) 1D
12 ივნ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BLRX...
Open
3,40 US$
High
3,60 US$
Low
3,37 US$
Mkt. cap
13,05 მლნ.
Avg. vol.
81,59 ათ.
Volume
51,29 ათ.
52-wk high
5,27 US$
52-wk low
2,16 US$
EPS
-0,49 US$
Beta
1,53
Shares outstanding
4,37 მლნ.
No. of employees
22
Open
3,40 US$
High
3,60 US$
Low
3,37 US$
Mkt. cap
13,05 მლნ.
Avg. vol.
81,59 ათ.
Volume
51,29 ათ.
52-wk high
5,27 US$
52-wk low
2,16 US$
EPS
-0,49 US$
Beta
1,53
Shares outstanding
4,37 მლნ.
No. of employees
22
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to BLRX in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for BLRX in the last 3 months.
Highest
Current 3,37 US$
12,00 US$ (+256,08%)
Average
12,00 US$ (+256,08%)
Lowest
12,00 US$ (+256,08%)
News stories
From sources across the web
Profile
BioLineRx Ltd., or BioLine, is a publicly traded drug development company. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Wikipedia
About BioLine RX Ltd - ADR
CEOფილიპ ეი სერლინ
Employees22
Founded2003
Headquarters-
Sector-
Websitebiolinerx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
ივნ. 2025
სექ. 2025
დეკ. 2025
მარ. 2026
Revenue
304,00 ათ.
427,00 ათ.
194,00 ათ.
477,00 ათ.
Cost of goods sold
72,00 ათ.
84,00 ათ.
40,00 ათ.
95,00 ათ.
Cost of revenue
72,00 ათ.
84,00 ათ.
40,00 ათ.
95,00 ათ.
Research and development expenses
2,33 მლნ.
1,72 მლნ.
2,42 მლნ.
2,53 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
209,00 ათ.
831,00 ათ.
1,12 მლნ.
858,00 ათ.
Operating expense
2,54 მლნ.
2,55 მლნ.
3,54 მლნ.
3,39 მლნ.
Total operating expenses
2,61 მლნ.
2,63 მლნ.
3,58 მლნ.
3,48 მლნ.
Operating income
-2,30 მლნ.
-2,21 მლნ.
-3,39 მლნ.
-3,00 მლნ.
Other non operating income
-1,85 მლნ.
1,16 მლნ.
1,10 მლნ.
458,00 ათ.
EBT including unusual items
-3,94 მლნ.
-977,00 ათ.
-2,24 მლნ.
-2,59 მლნ.
EBT excluding unusual items
-3,94 მლნ.
-977,00 ათ.
-2,24 მლნ.
-2,59 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3,94 მლნ.
-977,00 ათ.
-1,38 მლნ.
-1,60 მლნ.
Net profit margin
-1 296,05%
-228,81%
-713,92%
-335,64%
Earnings per share
-
-
-
-
Interest and investment income
490,00 ათ.
377,00 ათ.
-
208,00 ათ.
Interest expense
-276,00 ათ.
-304,00 ათ.
-288,00 ათ.
-250,00 ათ.
Net interest expenses
214,00 ათ.
73,00 ათ.
-288,00 ათ.
-42,00 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,13 მლნ.
-2,09 მლნ.
-3,33 მლნ.
-2,92 მლნ.
Gain or loss from assets sale
-
-
25,00 ათ.
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer